MedTrace Logo

Phenobarbital for Acute Alcohol Withdrawal

NCT01184417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2012-03-09

Study results available
· View outcomes & findings →

Summary

Intravenous phenobarbital in combination with a symptom-guided standardized lorazepam-based alcohol withdrawal protocol will be associated with decreased need for ICU admission, continuous lorazepam infusion and will not be associated with increased adverse events.

Conditions

  • Alcohol Withdrawal

Interventions

DRUG

10 mg/kg IV phenobarbital in 100 ml saline

10 mg/kg IV phenobarbital in 100 ml saline

DRUG

placebo

100 m l saline

Sponsors & Collaborators

  • Alameda County Medical Center

    collaborator OTHER

  • Jonathan Rosenson

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-03-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01184417 on ClinicalTrials.gov